Injongo yocwaningo

Inhloso yalolu cwaningo ukuhlola ukuphepha nokubekezelelana kanye nokuqinisekisa umthamo we-nemtabrutinib ngokuhlanganiswa ne-venetoclax kubahlanganyeli abane-R/R CLL/SLL. Imibono yocwaningo eyinhloko ukuthi inhlanganisela ye-nemtabrutinib kanye ne-venetoclax iphakeme kune-VR ngokuphathelene nokusinda kwe-progression-free (PFS) ngo-2018 International Workshop on Chronic Lymphocytic Leukemia (iwCLL) indlela yokuhlola njengoba ihlolwe yi- blinded independent central review (BICR).

Isihlonzi se- Clinicaltrials.gov

I-NCT05947851

I-EU CT

2022-501560-17-00

Lapho uxoxa nodokotela wakho noma ilungu leqembu locwaningo lwezokwelapha, sicela ube nenombolo yereferensi yocwaningo noma inombolo ye-EudraCT.

Izinsiza

Ukufaneleka

Uchwepheshe wezempilo uyena kuphela onganquma ukuthi uyafaneleka yini ukubamba iqhaza ocwaningweni lwezokwelapha. Nokho, lolu lwazi lungaba usizo ekuqaleni ingxoxo nodokotela wakho.

Izimo Icon

Izimo

I-Lymphocytic Leukemia engapheli, I-Lymphocytic Lymphoma encane, I-Lymphoma, I-Lymphoma Yamaseli Amancane, I-Lymphocytic Lymphoma encane

Ububanzi Bobudala Icon

Ububanzi Bobudala

18+

Ubulili Icon

Ubulili

Owesilisa/Insikazi

Zonke iziguli ezibhalisela ukuhlola zizothola imithi ngenkathi usocwaningweni.

Engxenyeni yoku-1, zonke iziguli zizothola i-nemtabrutinib ne-venetoclax

Engxenyeni yesi-2, ama-50% eziguli azothola i-nemtabrutinib ne-venetoclax

Engxenyeni yesi-2, ama-50% eziguli azothola i-venetoclax ne-rituximab

Trial phase Icon Isigaba socwaningo esiqhubekayo

Isigaba ISIGABA3 Socwaningo

Ezingcwaningweni Zesigaba 3, abacwaningi bazama ukuthola ukuthi umuthi ungasebenza yini enanini elikhulu labantu, ngokuvamile ababambiqhaza abayi-1,000 ukuya ku-5,000 abanesimo sempilo esizokwelashwa umuthi. Ezingcwaningweni zomgomo, ababambiqhaza bangaba abanempilo noma abanezifo noma izimo ezithile. Ucwaningo lwesigaba 3 lungenziwa ehhovisi likadokotela, emtholampilo, noma esibhedlela.

Trial start Icon Izinsuku zokuqala nokuqedwa kocwaningo
  • Usuku lokuqala kocwaningo Agasti 8, 2023
  • Usuku oluyinhloko lokuqeda olulinganiselwe Mashi 14, 2035
  • Usuku lokuqeda ucwaningo olulinganiselwe Mashi 14, 2035

Izindawo zocwaningo

Izindawo ezibonisiwe kungenzeka zishintshile kwezinye izimo. Sicela ushayele inombolo esohlwini lwemiphumela yendawo ukuqinisekisa isikhungo socwaningo esiseduze. Xoxa nelungu lesikhungo socwaningo ukuthola ulwazi olwengeziwe.

Yikuphi ongakwenza ngokulandelayo?

Uma ucabanga ukuthi lolucwaningo lwezokwelapha lungakulungela futhi unesithakazela sokubamba iqhaza, ukuthatha isinyathelo esilandelayo ukuze ubone ukuthi uyafaneleka yini.

Xoxa nodokotela wakho noma iqembu lokunakekela

Phrintha leli khasi elinemininingwane yocwaningo noma ulithumele nge-imeyili kudokotela wakho ukuxoxa ngocwaningo lwezokwelapha ekuvakasheni okulandelayo.

Thola usizo ngokuxoxa nodokotela wakho noma iqembu lokunakekela

Isihlonzi se- Clinicaltrials.gov

I-NCT05947851

I-EU CT

2022-501560-17-00

Lapho uxoxa nodokotela wakho noma ilungu leqembu locwaningo lwezokwelapha, sicela ube nenombolo yereferensi yocwaningo noma inombolo ye-EudraCT.

Ukubamba iqhaza ocwaningweni lwezokwelapha kuyisinqumo esibalulekile

Uma ucabangela ukujoyina ucwaningo lwezokwelapha, qala ngokufunda okuningi ngokunokwenzeka ngalo:

  • Umuthi wophenyo ocwaningwayo
  • Yiziphi izingozi noma izinzuzo ezingaba khona zababambiqhaza

Xoxa nodokotela wakho ngocwaningo lwezokwelapha ungakenzi isinqumo sokujoyina.

Funda ikhasi elithi “Ongakucabangela” ukuthola imibuzo eyengeziwe ongayibuza nongacabanga ngayo